In this article, the authors report six-year outcomes from the Evolut Low Risk trial, which randomized 1,414 low-risk patients with severe aortic stenosis to transcatheter aortic valve replacement (TAVR) (n=730) or surgery (n=684).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic Valve
February 26, 2026
February 26, 2026
In this brief report, the authors present an ex vivo bench study evaluating the impact of post-dilation strategies on Evolut FX+ transcatheter heart valves (23, 26, 29, and 34 mm). Valves were expanded in an elliptical annular model and underwent post-dilation using balloons either within or exceeding the instructions for use recommendations.
February 19, 2026
In this article, the authors present the three-year results of the randomized LYTEN trial comparing balloon-expandable valves (BEV; SAPIEN 3/ULTRA) and self-expanding valves (SEV; Evolut R/PRO/PRO+) for valve-in-valve transcatheter aortic valve replacement (TAVR) in failed small surgical aortic bioprostheses (≤23 mm).
February 19, 2026
In this article, the authors present a bench-to-animal-to-human proof of concept for valve-in-mechanical (ViMech) transcatheter aortic valve implantation (TAVI) in patients with failed bileaflet mechanical aortic valves. Bench testing showed disc dislodgement with balloon inflation at pressures of 2 to 4 atm, while snaring failed.
February 5, 2026
A systematic review and meta-analysis of six randomized controlled trials examined five-year outcomes comparing transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR) in 3,094 women with aortic stenosis (1,587 TAVR, 1,507 SAVR).
January 29, 2026
This first-in-human case report describes ventriculo-coronary transcatheter outward navigation and reentry (VECTOR), a novel percutaneous aorto-coronary bypass technique to prevent coronary obstruction during transcatheter aortic valve replacement.
January 8, 2026
This 10-year, single-center, propensity-matched study compared the outcomes of resident-led operations with those of consultant-led operations at a high-volume UK center.
December 18, 2025
This comparative study evaluated outcomes between surgical aortic valve replacement with Y-incision aortic annular enlargement (SAVR with Y-AAE) vs transcatheter aortic valve replacement (TAVR) in 362 low-to-intermediate risk patients with severe native aortic stenosis and small aortic annuli (≤25mm).
November 13, 2025
The authors report seven-year outcomes of the PARTNER 3 trial comparing transfemoral transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) in 1,000 low-risk patients with severe, symptomatic aortic stenosis.
October 30, 2025
The EACTS recently released an expert consensus statement on the Ross procedure in adult patients, highlighting the renewed focus in this area due to increasing evidence of excellent long-term outcomes. These outcomes include restoration of life expectancy and improved valve-related outcomes.